Modern parenting can be difficult, but SolePath's Dr. Debra Ford believes that those parents who adopt the SolePath method into their parenting will be able to create a stronger bond between themselves and their child.

Ms. Marilyn Klinger of Los Angeles, California, is honored by the International Association of Who's Who as one of America's Most Influential Attorneys for her achievements within the field of Law.

Author of 5 bestselling books shares her journey from finding validation from others to receiving validation from God and herself. A Struggle for the Crown that always belonged to her.

Cynthia Garnholz, of St. Louis, Missouri, is recognized by the International Association of Who's Who as one of America's Most Influential Attorneys for her extensive achievements within the field of Law.

The exciting story of an epic effort by two women racers to field an all-female driving team for the 25 Hours of Thunderhill ––– America's iconic endurance race.

Gray hair & roots take priority as personal appearance prompts run on hair dye at stores

Employers Find eRep's Services Indispensable in Pivotal Hiring Market

Intellectual disability coaching site now accepting scholarship applications and donations

The Branded Products and Marketing Services Franchise is a One-Stop Shop to Raise School Spirit

The notable eclectic high-end boutique interior design firm is recognized among New York Leading Designers

Charity for the arts/culture

Finally, a modest swimwear brand that's actually designed for modern women.

Fight clubs and fashion designers are betting on "The Bronze Bomber" worn by Deontay Wilder, designed by Cosmo & Donato.

Group Adds Special Closet Sale and Wish List Days to Make Buying and Selling RG Items Easier

Make her a hand made DIY mask, stitched with love!

The Connecticut law firm was honored in the personal injury and medical malpractice fields by the prestigious U.S. News - Best Lawyers 'Best Law Firms' publication.

TOP platform is an international campaigner that invites all freelancers no matter where they might be in the world to sign up and explore the opportunity to make money online by offering services through this digital marketing agency.

The most popular automotive trends, car makes or technologies of 2019 in a nutshell

Many homeowners struggling financially in the coronavirus pandemic worry mortgage servicers will require them to repay mortgage bills all at once.

(Bloomberg) -- Wall Street’s biggest firms are divided on where markets are heading to next.While most risk assets are well off their mid-March lows, when uncertainty about the global impact of the coronavirus outbreak was at its peak, there is little consensus on what is to follow. At the core of the debate is the long-term effectiveness of the massive stimulus from central banks and governments.When $8 Trillion in Global Fiscal Stimulus Still Isn’t EnoughCitigroup Inc., for one, doesn’t get the “puzzling” rise in stocks.“Extensive policy response, led by ample liquidity provided by central banks, likely contributed to the move in the markets,” economists including Igor Cesarec and Catherine Mann wrote in a note Thursday. “However, since it is not clear that markets can be propped up indefinitely, caution is warranted. Risk assets could be fragile once the cold, hard economic reality hits again.”On the other hand, JPMorgan Chase & Co. sees the stock market advance as justified -- and one which can continue.“While the collapse in economic activity is historic, so too is the global policy response to cushion the impact and support a recovery,” strategists led by Marko Kolanovic wrote in a note Thursday. “We expect risky assets to continue to recover as economies reopen and given the unprecedented policy support, though we expect a moderation in the pace of gains.”Read about JPMorgan’s call in late March that markets were probably past the worst.The MSCI AC World Index has climbed about 25% since March 23 as investor sentiment warmed toward a slew of worldwide policy measures to offset the economic impact of the pandemic. The global gauge had fallen as much as 34% from its February high, when concerns about the virus reached a peak.Looking ForwardGoldman Sachs Group Inc. and Morgan Stanley largely see gains remaining intact, with caveats.Goldman attributes the market rise to a stabilization in virus infection rates and an improvement in measures of funding and liquidity stress. The firm has already said that equities price in macroeconomic performance over a two-year time horizon and investors may look past huge economic damage.“Markets will continue to look through bad news about the depth of the economic downturn if they can continue to hold on to their view that a sizable chunk of the recent damage will be reversed by the end of next year,” strategists including Zach Pandl wrote in a note Tuesday.And Morgan Stanley is also comfortable with the disparity between asset price performance and fundamentals, noting that markets tend to lead the economy and care more about rate of changes than absolute levels.“Divergences between the market and economy are common at economic extremes,” wrote strategists including Andrew Sheets in a note Thursday. “Rate of change is key – a ‘U’ shaped recovery is fine, a ‘W’ is not.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. A new antibody test is highly accurate at determining whether people have been infected with the novel coronavirus, according to a study published on Friday in The Journal of Clinical Microbiology. Researchers at the University of Washington School of Medicine found the test, manufactured by Abbott Laboratories, had a specificity rate of 99.9% and a sensitivity rate of 100%, suggesting little chance of incorrectly diagnosing a healthy person as having been infected and virtually no chance of a false negative readout.

Director of Fiscal Policy at the American Action Forum Gordon Gray joins Yahoo Finance’s Seana Smith to break down the April jobs report and how some workers are making more on unemployment compared to their wages before the coronavirus pandemic.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Moody’s Analytics analyzed U.S. metro areas capabilities for a strong recovery post-coronavirus using two primary factors: population density and educational attainment.

What happened to my stimulus money? Many who receive government benefits and others continue to wonder in early May.

General Electric (GE) shares have been on the decline as of late. As a result, many investors have been understandably worried. Such sentiments have placed the American manufacturing giant on the market spotlight, and begs the question: is it still worth investing in at current levels? Traversing turbulent market conditions, the outlook seems bleak for the 128-year-old conglomerate. Is there no way up for the aviation unit of General Electric? What about its other subsidiaries? Investor James Richman bets GE is likely to touch down $5-level. From there, the tech investor is bullish that the price will double in value and hit $10 again.Source: Flickr GE: a legacy of over 120 yearsAmid the impact of coronavirus specifically in both travel and hospitality industries, GE's esteemed aviation unit has been feeling the most pressure. The demand for airplanes has shrunk tremendously forcing the company's management to schedule a 25% workforce reduction globally. This is in consonance to the 10% layoff in its US workforce which was announced in March. These difficult cost-cutting measures are deemed necessary by David Joyce, CEO of the GE Aviation Unit that employs a workforce of around 52,000 people.Significant drops since coronavirusGE Aviation supplies jet engines to giant aircraft makers like Airbus and Boeing. The projection of Boeing, a 10% workforce drop amidst its $641m loss, certainly adds up to GE's current woes.  Investor betting on the company bouncing backHowever, one investor who is known to take a different outlook is Latvian-born investor James Richman. With investments in both public and private companies, and his most notable investments including tech giants such as Uber, Tesla, and Facebook, his approach is understood to be contrarian. Yahoo! Finance reports he is taking the opposite approach when compared to Warren Buffet as Richman bets GE's price to temporarily touch upon $5-level. From that level, it is projected to climb its way back to $10, making the 100% rally. The Monaco-based investor has also made headlines when he reportedly pledged $18m in the fight against coronavirus as he mobilizes his biomedical investments in the said efforts. Richman has been historically known to take the contrarian approach in investing. With investments that seemed unorthodox at one point, he has earned respect in the finance field because of his firm's outstanding performance during the 2008 financial crisis. Not open to the general public and mainly dealing with ultra high net worth individuals (UHNWI) and institutional investors, his clients have reported impressive annual earnings for over a decade.Comparison to the last financial crisisIt is not the first time GE had felt the backlash of market recessions. In 2008, the company's shares dropped by 78% tracing the period of the global recession. In 2 years, GE's shares dropped from $27 to $6. The broader S&P also fell that time, but with a conservative 51%.Still worth buying at current levels?GE recovered from the 2008 recession with tremendous momentum. After being bailed out by the federal government to the tune of $139 billion, it experienced an 82% uptick between March 2009 and January 2010. This is more than the 48% bounce back the S&P managed over the same period. Generally, the performance of its stock will still hinge on the developments in the handling of coronavirus pandemic, considering that the aviation division of the company is being hammered as a result. Efforts of which have been showing positive signs of recovery. Meanwhile, the demand for healthcare, government interventions, and the continuous development of treatments and vaccines is seen to help push the shares towards upwards direction in the long run: provided that its wings can weather the storm like it did in 2008.  More recent articles from Smarter Analyst: * RBC: 2 Strong Value Stocks to Buy Now * Look Beyond 2Q, General Motors Will Outperform the Sector, Says Analyst * Coronavirus Vaccine Could Add Massive Value to This Small-Cap Stock, Says Analyst * Can Seanergy Maritime Stock Add 150% Over the Next Year? This Analyst Says 'Yes'

Investors are still uncertain just where the stock market is headed. Essentially, there are two competing opinions right now. One says that we’re just in a bear market rally, and that the worst is yet to come. The other thesis states that the current rally is real, and will mature into a new bull cycle as the economy restarts in the second half.Writing from JPMorgan, Marko Kolanovic, the investment bank's quant analyst, holds fast to that optimistic view. Kolanovic believes that epidemiological data suggests we are past the worst of the coronavirus spread, justifying the lifting of social and business restrictions. And that will open up economic activity, which will then find stimulus from low Fed interest rates and increased government ‘pump priming’ spending.Kolanovic sees the stimulus policies as more important than Q1’s weak earnings, writing, “The combined suppression of the risk free rate and credit spreads by the Fed likely has a bigger positive impact on equity valuation, compared with the negative impact of the temporary earnings loss.”Kolanovic is not the only JPM analyst who sees potential in the stock markets. The firm’s equity analysts have been working overtime to find the stocks best positioned to lead a potential bull rally. We’ve used the TipRanks database to pull up three of their stock picks, to find out why the JPM experts are tapping them for over 30% growth.KAR Auction Services (KAR)The first stock on our list belongs to a company in the second-hand vehicle market. KAR Auction Services operates a marketplace – both online and in the physical world – for used vehicles. The company sells to both individual and business buyers, people looking for a car to drive and garages looking to source parts for the shop floor. KAR sold over 3.7 million vehicles in 2019, bringing in $2.8 billion in auction revenue.KAR shares have been hit hard by the coronavirus epidemic. The combination of economic shutdowns and social lockdowns have not just put a hold on car sales – they have simply reduced the need for vehicles.Q1 earnings showed a 6% reduction in revenue, to $645.5 million, and a collapse in net income to $2.8 million from $15.3 million in the year-ago quarter. As noted, these steep reductions are attributable to the effects of the pandemic response. KAR shares are still down 38% year-to-date, badly underperforming the broader markets.However, JPM’s analyst Ryan Brinkman believes the current downturn is the time to buy in to KAR shares. The low price offers an attractive point of entry, and the stock has a clear path forward when economic activity resumes. Brinkman writes, “We believe that once stay-at-home orders are lifted and the situation moves from being one of a unique public health crisis to that of a more familiar economic downturn, aftermarket end-markets, including auctions, will earn their reputation for resiliency. People will drive again substantially similar to before, and volumes will return to salvage auctions.”Along with that optimistic assessment, Brinkman upgrades KAR from Neutral to Buy. His $19 price target suggests a strong 46% upside potential in the next 12 months. (To watch Brinkman’s track record, click here)Overall, KAR shares hold a Moderate Buy rating from the analyst consensus, which breaks down into 4 Buy reviews and 3 Holds. While the analyst corps is somewhat divided, their average price target is in line with Brinkman’s. (See KAR stock analysis at TipRanks)J2 Global Communications (JCOM)Next up is an internet communications company. J2 Global owns a diverse portfolio of 40+ online content brands, including IGN, Mashable, PCMag, BabyCenter, Everyday Health among others. In addition, J2 also runs a Cloud Service business, offering eFax and eVoice among other online services. The company boasts nearly $1.5 billion in annual revenue, and saw Q4 earnings rise to $2.19 per share.The Q4 earnings were the highest in two years, and capped a full year of rising earnings. Q4 is typically J2’s strongest quarter, while Q1 is typically the weakest, so the $1.35 estimate for Q1 earnings is less indicative of poor performance than one may think at first. On an important note, that Q1 estimate represents a modest increase of 1.5% year-over-year.JCOM shares’ price performance has roughly mirrored the broader market’s during the past three months. JCOM lost 35% in the initial slide, and has risen 21% from its trough.Initiating coverage of the stock for JPM, Cory Carpenter set a Buy rating, with a $105 price target that indicates room for 32% upside growth. (To watch Carpenter’s track record, click here)Supporting his stance, Carpenter notes the company’s strong Cloud position, writing, “We believe Cloud Services is well positioned to capitalize on growing security & privacy needs, with bundling & cross-sell potential, and we like that Digital Media monetizes through multiple rents—ads, subs, & affiliate commerce.”Key drivers for Carpenter's bull thesis include: "1) Total growth strategy drives sustainable growth, with $1B+ capital to deploy [...] 2) Diversified portfolio of leading Cloud Services & Digital Media brands. [...] 3) Strong FCF generator with M&A flywheel. JCOM prioritizes FCF, not growth at all costs, which it largely redeploys into M&A. JCOM’s 40% EBITDA margin is driven by Cloud Services’ ~50% margin and Digital Media’s ~35% margin."Carpenter is broadly in line with the rest of Wall Street, which has assigned JCOM more "buy" ratings than "holds" over the past three month -- and sees the stock growing about 26% over the next 12 months, to a target price of $101.30. (See J2 Global stock analysis on TipRanks)Montage Resources Corporation (MR)Last on our list is a small-cap hydrocarbon exploration and production company. Montage is based in the Appalachian region of Pennsylvania, Ohio, and West Virginia, where it operates natural gas and crude oil drilling wells. Montage holds over 195,000 undeveloped core acres, and operates 325 actively producing horizontal wells. The value of the company’s holdings is clear from its stock performance; in the last three months, while the markets have generally slid into a bear cycle, MR shares have gained 55%.Even with the COVID-19 epidemic and the collapse of oil markets, MR was able to increase its net daily production during Q1, reaching 6610.7 MMcfe. This was above both company guidance and analyst estimates. Quarterly income of $62.7 million also beat the expectations. The company has curtailed some production in low-margin crude oil, to compensate for the soft oil market prices.Analyst Arun Jayaram, reviewing MR for JPM, upgraded his stance on the shares from Neutral to Buy. His $8 price target implies a 43% upside growth potential for the coming year. (To watch Jayaram’s track record, click here)Jayaram is clear on his reasons for upgrading this stock. He says of MR, “We expect the market to largely look through negative estimate revision risk to 2020 forecasts to the emerging bullish natural gas narrative in 2021… Meanwhile, the company’s FCF yield of 23% leads the peer group and is well above the peer group average of 10%...”The Strong Buy analyst consensus on MR shares is based on 5 recent reviews, including 4 Buys and a single Hold. The company’s strong natural gas production is tangible asset, and its enviable free cash flow is attractive for investors. Shares are selling for $5.59, while the average price target of $6.22 suggests a modest upside of 1.6%. (See MR stock analysis at TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Cloud security company Ermetic emerged from stealth mode this week with a platform that automates detection and remediation of identity and access-based risks.

read more

Extreme endurance motorcycle rider to attempt 9th world record, "Greatest Distance on a Motorcycle in 24 Hours (Individual)" this weekend in Uvalde, Texas. Follow live at www.carlreese.net starting on February 24, 2017.

Motorcycle enthusiasts are encouraged to take advantage of the European riding season and attend the world's largest BMW motorcycle party.

Austin personal injury attorney Chip Evans said the state ranks among the worst in the nation for motorcycle safety. Texas is behind only South Carolina and Mississippi in the number of number of motorcycle fatalities per registered motorcycles.

The global automotive aftermarket is rapidly evolving, with demand for starter solenoids being higher than before. T&X Starter Solenoid Manufacturers moved in supply the growing market, and their products have gained popularity the world over.

WeeTect announces its new generation of photochromic visor inserts.

Typically used on older Chevy Impala, Chevy Caprice or even Datsun 280Z, rivet on the body side molding is an add-on accessory that was installed at car dealerships over in the 70's and 80's.

Columbia attorney Mark Evans encourages drivers and lawmakers alike to improve Missouri's poor record on road safety.

Sanford, Florida Power Sports Dealership Continues Partnership with Kyle Farnell

BurnsOffroad, a free app available in the AppStore and Google Play, is a must-have for those who love riding ATVs, SSVs, 4x4s, and other off-road vehicles.

RideClean is an all-in-one premium ultra polisher & sealer and it's made in the USA.

Co-Founders discuss the execution of their vision and exciting future plans

The American fashion designer Victoria Napolitano will collaborate with Luca Caputo, a talented Italian with a passion for restoring classic cars and motorbikes.

To accommodate rapid growth and expansion of the product line, BMS promotes one of their top dealers to lead them into the next decade.

In celebration of National Motorcycle Safety Awareness Month, Personal Injury Attorney Ed Smith Offers Tips to Help Motorcyclists Ride Safely

D. Miller & Associates, PLLC hosted the third annual motorcycle ride to raise money for those affected by traumatic brain injury.

The Transportation Equity Network (TEN) has released More Transit = More Jobs: The Impact Of Increasing Funding For Public Transit (31p. PDF). TEN is a coalition of more than 350 grassroots organizations in 41 states that has worked since 1997 to build a more just, prosperous, and connected America.

This study asks two key questions:

What would be the effect on jobs in each metropolitan area of shifting 50% of the money spent on highways to public transit?

How many jobs would be created in each metro area if we increased funding on public transit at the rate indicated by the Transportation For America proposal for the next transportation authorization act?

The report highlights several statistics in answering those questions based on data from Transportation Improvement Programs (TIPS) in 20 U.S. metropolitan areas. For example, 1,123,674 new transit jobs would be created over a 5-year period for a net gain of 180,150 jobs without a single dollar of new spending.

However, if federal spending on transit increased as proposed by TEN and Transportation For America, an estimated 1.3 million jobs over the life of the law would be created, as well as almost 800,000 more jobs than under present federal transporation law (SAFETEA-LU).

The Federal Highway Administration published the 2009 Urban Congestion Trends (8p. PDF) document last week. This brief report utilizes a dashboard format to convey year-over-year changes in key traffic measures: daily hours of congestion, time penalty for eqach trip, worst-trip time penalty. Some key observations include:

• Overall, congestion had declined in almost all monitored regions between 2008 and 2009
• Less wasted time and fewer hours of the day were devoted to stop-and-go traffic in 16 of the 23 monitored regions
• At least one of the three measures improved in 20 of the 23 monitored regions
• Congestion is lowest during the summer vacation season

The report goes on to explain how operational improvements can mitigate congestion and promote smooth, safe and consistent traffic flow.

Examples provided from around the country include high-occupancy/toll lanes, freeway ramp metering, improved information coordination, work-zone management, and traffic signal system improvement programs.

In Managing Increasing Ridership Demand (32p. PDF), The FTA's Transit Cooperative Research Program presents an overview of a study mission investigating how several transit operators and agencies in Latin America accomodate sudden and significant growth in the number of riders and increasing demand for service.

Case studies from Guayaquil (Ecuador), Santiago (Chile), Buenos Aires (Argentina) and Porto Alegre (Brazil) were selected because they have faced and successfully dealt with challenges similar to recent ridership grown in the United States.

Each city's responses offer unique insight into managing increasing transit ridership and providing various perspectives on serving the mobility needs of their communities.

Two International Transit Studies Program study missions such as this are conducted each year. They have three objectives: To afford team members the opportunity to expand their network of domestic and international public transportation peers, to provide a forum for discussion of global initiatives and lessons learned in public transportation, and to facilitate idea sharing and the possible import of strategies for application to transportation communities in the United States.

The organization CEOs For Cities released a widely-cited report last month titled Measuring Urban Transportation Performance: A Critique Of Mobility Measures And Synthesis (71p. PDF). Their research finds that the secret to reducing the amount of time Americans spend in peak hour traffic has more to do with how we build our cities than how we build our roads.

The report explains how the cities studied have managed to achieve shorter travel times and actually reduce the peak hour travel times. Some metropolitan areas have land use patterns and transportation systems that enable their residents to take shorter trips and minimize the burden of peak hour travel.

This runs counter to the conclusions of the Texas Transportation Institute's Urban Mobility Report year after year. The CEO For Cities document explains that the UMR approach has completely overlooked the role that variations in travel distances play in driving urban transportation problems.

In the best performing cities -- those that have achieved the shortest peak hour travel distances -- such as Chicago, Portland and Sacramento, the typical traveler spends 40 fewer hours per year in peak hour travel than the average American. Because of smart land use planning and investment in alternative transportation, Portland has seen its average trip lengths decline by 20%.

In contrast, in the most sprawling metropolitan areas, such as Nashville, Indianapolis and Raleigh, the average resident spends as much as 240 hours per year in peak period travel because travel distances are so much greater. The report's 20-page Executive Summary is titled Driven Apart: How Sprawl Is Lengthening Our Commutes And Why Misleading Mobility Measures Are Making Things Worse.

In The New Sharing Economy, a study by Latitude in collaboration with Shareable Magazine, the authors look at new opportunities for sharing.

An interesting graph (click to enlarge) plots various endeavors on a market saturation and latent demand scale. The resulting plot points fall into four quandrants, labeled:

Low Interest and Low Prior Success (e.g. bike, outdoor sporting goods)

Done Well Already (e.g. work space, storage space, food co-op)

Opportunities Still Remain (e.g. physical media, digital media)

Best New Opportunities (automobile, time/responsibilities, money lending/borrowing)

This last category, Best New Opportunities, provides the launch point for discussion of car sharing. The report notes that there's still a large amount of unfulfilled demand for car-sharing. More than half of all participants surveyed either shared vehicles casually or weren't sharing currently but expressed interest in doing so. For people who share in an organized fashion, cars and bikes were popular for sharing amongst family and close friends but weren't commonly shared outside this immediate network, relative to other categories of goods.

This intriguing and visually appealing report goes on to point out the new sharing takeaways for non-sharing businesses, including "we-based brands," the value in social and alternative currencies, and the "contagiousness" of sharing.

Finally, Transportation For America recently released a White Paper titled Smart Mobility For A 21st Century America: Strategies For Maximizing Technology To Minimize Congestion, Reduce Emissions And Increase Efficiency (39p. PDF).

It proposes that improving transportation efficiency through operational innovation is critical as our population grows and ages, budgets tighten and consumer preferences shift.

As Congress prepares to review and reauthorize the nation’s transportation program, an array of innovations that were either overlooked or did not exist at the time of previous authorizations can be incentivized.

Just as the Internet, smart phones and social media changed they way we acquire news, listen to music or connect with friends and family, these same innovations have implications for how we move around. While high-tech gadgets can be a problem when they distract motorists from driving, they open up a whole new world for people using other modes.

But what if we could manage traffic to help drivers avoid congestion before they get stuck in it? What if you always knew when the next bus was going to arrive, the closest parking space or which train car had a seat available for you? The innovative technologies and strategies outlined in the White Paper include:

Making transportation systems more efficient (e.g. ramp meters, highway advisory radio)
Providing more travel options (e.g. online databases to match up vanpool riders, car-sharing services)
Providing travelers with better, more accurate, and more connected information (e.g. computerized vehicle tracking)
Making pricing and payments more convenient and efficient (e.g. EZ passes, electronic benefits)
Reducing trips and traffic (flex-time, consolidating services online)

The report goes on to discuss changes in demographics and make recommendations for federal transportation policy, as well as highlight several intriguing "smart mobility case studies."

Visit us at http://metroprimaryresources.info and update your links. After 5 seconds, you will be automatically redirected.